For the Quarter Ending September 2025
North America
• In United States, the Piperazine 68 Price Index rose quarter-over-quarter in Q3 2025, driven by significant increases in production costs.
• Piperazine 68 production costs increased in Q3 2025, with a 2.6% rise in PPI in August 2025 and higher natural gas prices.
• Demand for Piperazine 68 faced headwinds as industrial production grew only 0.1% year-over-year in September 2025.
• Consumer confidence declined to 94.2 in September 2025, dampening demand for consumer-facing products utilizing Piperazine 68.
• Retail sales increased 5.42% year-over-year in September 2025, offering some indirect support for certain end-use applications.
• Raw materials and finished goods inventories for chemical manufacturers remained stable or contracted in Q3 2025.
• U.S. chemical production levels contracted in Q3 2025, with no significant capacity expansions planned for the year.
• Foreign orders for U.S. chemical manufacturers fell in Q3 2025, impacting overall trade flows for Piperazine 68.
Why did the price of Piperazine 68 change in September 2025 in North America?
• Rising input costs, evidenced by a 2.6% PPI increase in August 2025, pressured Piperazine 68 prices upward.
• Increased energy and natural gas prices in Q3 2025 significantly contributed to higher production expenses.
• Weak industrial production, up only 0.1% in September 2025, moderated potential price increases from demand.
APAC
• In China, the Piperazine 68 Price Index fell quarter-over-quarter in Q3 2025, driven by contracting manufacturing activity.
• The Piperazine 68 price forecast indicates continued downward pressure from persistent chemical market overcapacity.
• Production costs for Piperazine 68 trended lower in Q3 2025, influenced by significant oversupply of key precursor ethylene.
• Piperazine 68 demand outlook remained cautious, with domestic demand soft despite 3.0% retail sales growth in September.
• The Manufacturing Index was contracting in September 2025, signaling reduced industrial activity, impacting consumption.
• Raw material inventories tightened in July and August 2025, with the decline narrowing in September.
• China's total goods imports and exports increased in Q3 2025; new export orders strengthened in September.
• Consumer confidence at 89.6 and CPI decreasing 0.3% in September 2025 signaled dampened overall demand.
• Industrial production expanded 6.5% year-over-year in September 2025, while unemployment remained at 5.2%.
Why did the price of Piperazine 68 change in September 2025 in APAC?
• Weak industrial demand was evident as the Manufacturing Index contracted in September 2025.
• Producer prices declined, with PPI falling 2.3% year-over-year in September 2025.
• Oversupply of key feedstock ethylene and market overcapacity pressured prices.
Europe
• In Germany, the Piperazine 68 Price Index remained stable quarter-over-quarter in Q3 2025, influenced by mixed market signals.
• Piperazine 68 production costs remained elevated in Q3 2025, despite a 1.7% year-over-year PPI decrease in September 2025.
• The Piperazine 68 Demand Outlook is mixed, with pharmaceutical sector growth offsetting industrial production declines.
• Germany's industrial production declined 1.0% in September 2025, reducing demand for chemical inputs like Piperazine 68.
• The Manufacturing Index for Q3 2025 was contracting, signaling a slowdown in new orders for Piperazine 68 end-uses.
• Retail sales in Germany rose by 0.2% in September 2025, offering slight support for consumer-driven Piperazine 68 applications.
• Elevated natural gas costs and rising CPI of 2.4% in September 2025 pressured Piperazine 68 production.
• Low capacity utilization and historically low order backlogs in July 2025 impacted future Piperazine 68 demand.
• The Piperazine 68 Price Forecast suggests continued stability, balancing cost pressures with subdued industrial demand.
Why did the price of Piperazine 68 change in September 2025 in Europe?
• Producer prices decreased 1.7% year-over-year in September 2025, easing Piperazine 68 manufacturing costs.
• Industrial production declined 1.0% in September 2025, dampening Piperazine 68 demand across sectors.
• Elevated raw material and energy costs in Q3 2025 maintained upward pressure on Piperazine 68 production.
